Sialix Cancer Research
Cambridge, Massachusetts, United States · Founded 2013
About Sialix Cancer Research
Sialix Cancer Research provides cancer susceptibility antibodies and cancer-associated nucleoprotein antibodies for breast cancer. They also offer laser-based photodynamic endoscopic diagnosis using 5-aminolevulinic acid for early gastric adenocarcinoma and gastric adenoma.
Company Facts
- Founded: 2013
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.2M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2014)
- Website: http://sialix.com
Industries & Categories
Biotechnology, Health Care, Oncology
Canonical: https://fsome.com/organization/sialix-cancer-research-2493113 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.